cytidine monophosphate n-acetylneuraminic acid has been researched along with Benign Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abu Izneid, T; Al Saoud, R; Hamrouni, A; Idris, A; Mousa, WK | 1 |
| Bauer, C; Gerok, W; Köttgen, E; Reutter, W | 1 |
1 review(s) available for cytidine monophosphate n-acetylneuraminic acid and Benign Neoplasms
| Article | Year |
|---|---|
Recent advances in the development of sialyltransferase inhibitors to control cancer metastasis: A comprehensive review.
Topics: Cytidine Monophosphate N-Acetylneuraminic Acid; Humans; N-Acetylneuraminic Acid; Neoplasms; Polysaccharides; Sialyltransferases | 2023 |
1 other study(ies) available for cytidine monophosphate n-acetylneuraminic acid and Benign Neoplasms
| Article | Year |
|---|---|
[Glycoproteins: their biological and clinical significance. I (author's transl)].
Topics: Autoimmune Diseases; Cell Membrane; Cytidine Monophosphate N-Acetylneuraminic Acid; Female; Fucose; Glucosyltransferases; Glycoproteins; Humans; Male; Maternal-Fetal Exchange; Models, Biological; Neoplasms; Pregnancy | 1979 |